Date Filed | Type | Description |
05/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/17/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/14/2023 |
SC 13G/A
| SB Global Advisers Ltd reports a 8.6% stake in Pear Therapeutics, Inc. |
02/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
01/12/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
01/10/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
01/04/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
01/04/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
01/03/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
01/03/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
01/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
01/03/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
11/14/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
09/16/2022 |
SC 13D/A
| 5AM Ventures IV, L.P. reports a 12.2% stake in Pear Therapeutics, Inc. |
08/11/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/11/2022 |
8-K
| Quarterly results |
07/25/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
07/25/2022 |
8-K
| Quarterly results |
06/24/2022 |
8-K
| Quarterly results |
06/15/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/15/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/15/2022 |
8-K
| Quarterly results |
06/06/2022 |
8-K
| Quarterly results |
05/16/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/16/2022 |
8-K
| Quarterly results |
05/12/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/12/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/12/2022 |
8-K
| Quarterly results |
05/02/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|